• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1988 Fiscal Year Final Research Report Summary

Studies on the enhancement of maxrophage killing by the selective activation of their tumoricidal activity and tumor cell modi-ication

Research Project

Project/Area Number 61570611
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field General surgery
Research InstitutionHiroshima University

Principal Investigator

TOGE Tetsuya  Lecturer, Hiroshima University Hospital, 医学部附属病院外科(原医研), 講師 (40034657)

Co-Investigator(Kenkyū-buntansha) YANAGAWA Etsuro  Lecturer, Research Institute for Nuclear Medicine & Biology, Hiroshima Universit, 原爆放射能医学研究所外科, 講師 (40136148)
Project Period (FY) 1986 – 1988
KeywordsActivated macrophages / Tumor susceptibility / Surface structure
Research Abstract

To develop the tumor cell destruction by activated macrophages, the enhancement of tumor cell susceptibility to macrophage binding and cytolysis, and the selective activation of tumoricidal macrophages were investigated. Tumoricidal activity of activated macrophages against MM102 and MH-134 tumor cells were significantly enhanced when tumor cells were pretreated with 0.1KE/ml of OK-432 for 2 hr. Furthermore, these tumor cells pretreated with OK-432 showed no changes on their surface structure by the SEM examination and binding and cytolysis of activated macrophages against OK-432 pretreated tumor cells were significantly enhanced, suffesting that macrophage killing activities were enhanced by the modification of tumor cells.
For the further analysis of action mechamisms of macrophage activation by BRM, morphological changes of surface structure of macropahges fractionated with the uptake of FITC-conjugated OK-432 were investigated. Macrophage population among peritoneal exsudate cells was 39.3% in mice treated with ip injection of FITC-OK432, while that was 17.0% without OK-432 injection. The populations of cells with intracelluar OK432 were 15.8% in macrophage fraction amd 2.1% in lymphocyte one, respectively. Macrophages with intracelluar OK432 showed well developed ruffles and the appearance of lamellipodia on their surface structure, resembling tumoricidal macrophages.

  • Research Products

    (9 results)

All Other

All Publications (9 results)

  • [Publications] Toge,T.: Int.J.Immunopharmac.8. 599-603 (1986)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 峠哲哉: 癌と化学療法. 13. 1258-1263 (1986)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 峠哲哉: 医学の歩み. 140. 786-788 (1987)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 峠哲哉: 日臨免会誌. 10. 10-19 (1987)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 峠哲哉: 臨床免疫. 20. 724-730 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Toge,T.: Jpn.J.Surg.18. 668-674 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Toge, T., et al.: "Correlation between the presence of intracellular OK-432 and antitumor acti-vity of peritoneal macrophages." Int. J. Immunopharmac.8. 599-603 (1986)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Toge, T., et al.: "The clinical efficacy of intratumoral OK-432 administration in advanced cancer" Jap. J. Surg.,. 18. 668-674 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Toge, T., et al.: "Intratumoral administration of BRM" J. Clin. Immunol., (Rinsyou Meneki). 20. 724-730 (1988)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1990-03-20  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi